array:18 [ "pii" => "S2444440524001110" "issn" => "24444405" "doi" => "10.1016/j.rcreue.2024.07.005" "estado" => "S300" "fechaPublicacion" => "2024-07-01" "aid" => "2065" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "pgl" "cita" => "Rev Colomb Reumatol. 2024;31:365-79" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Consensus statement</span>" "titulo" => "Clinical practice guideline for the prevention, diagnosis, and treatment of glucocorticoid-induced osteoporosis. Colombian Association of Rheumatology, 2023" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "365" "paginaFinal" => "379" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Guía de práctica clínica para la prevención, el diagnóstico y el tratamiento de la osteoporosis inducida por glucocorticoides. Asociación Colombiana de Reumatología, 2023" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2960 "Ancho" => 3341 "Tamanyo" => 619565 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Algorithm for the prevention, evaluation and management of glucocorticoid-induced osteoporosis in adults.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">*Or equivalent doses.</p> <p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">**Initial dose ≥ 30 mg of prednisolone for more than 3 months or cumulative dose > 5 g in one year, or its equivalent.</p> <p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">****Paraclinical tests before starting therapy: glucose, kidney and thyroid function and others, depending on comorbidities and general condition.</p> <p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">IV bisphosphonate: zoledronic acid; oral biphosphonate: alendronate, risedronate; DXA: Dual-energy X-ray absorptiometry; AE: Adverse events; FRAX: fragility fracture risk calculation instrument; GC: glucocorticoids; IV: intravenous.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Monique Chalem, Noemi Casas, Aura María Domínguez, Daniel Gerardo Fernández, Andrés González, Edwin Jáuregui, José Fernando Molina, Diana Nathalie Rincón, Carlos Enrique Toro-Gutiérrez, Francisco Juan Vargas Grajales, Susan Martínez, Linda Ibatá" "autores" => array:12 [ 0 => array:2 [ "nombre" => "Monique" "apellidos" => "Chalem" ] 1 => array:2 [ "nombre" => "Noemi" "apellidos" => "Casas" ] 2 => array:2 [ "nombre" => "Aura María" "apellidos" => "Domínguez" ] 3 => array:2 [ "nombre" => "Daniel Gerardo" "apellidos" => "Fernández" ] 4 => array:2 [ "nombre" => "Andrés" "apellidos" => "González" ] 5 => array:2 [ "nombre" => "Edwin" "apellidos" => "Jáuregui" ] 6 => array:2 [ "nombre" => "José Fernando" "apellidos" => "Molina" ] 7 => array:2 [ "nombre" => "Diana Nathalie" "apellidos" => "Rincón" ] 8 => array:2 [ "nombre" => "Carlos Enrique" "apellidos" => "Toro-Gutiérrez" ] 9 => array:2 [ "nombre" => "Francisco Juan" "apellidos" => "Vargas Grajales" ] 10 => array:2 [ "nombre" => "Susan" "apellidos" => "Martínez" ] 11 => array:2 [ "nombre" => "Linda" "apellidos" => "Ibatá" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0121812323000609" "doi" => "10.1016/j.rcreu.2023.06.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0121812323000609?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444440524001110?idApp=UINPBA00004N" "url" => "/24444405/0000003100000003/v1_202409200646/S2444440524001110/v1_202409200646/en/main.assets" ]
Journal Information
Vol. 31. Issue 3.
Pages 365-379 (July - September 2024)
Vol. 31. Issue 3.
Pages 365-379 (July - September 2024)
Consensus statement
Clinical practice guideline for the prevention, diagnosis, and treatment of glucocorticoid-induced osteoporosis. Colombian Association of Rheumatology, 2023
Guía de práctica clínica para la prevención, el diagnóstico y el tratamiento de la osteoporosis inducida por glucocorticoides. Asociación Colombiana de Reumatología, 2023
Monique Chalem, Noemi Casas, Aura María Domínguez, Daniel Gerardo Fernández, Andrés González, Edwin Jáuregui, José Fernando Molina, Diana Nathalie Rincón, Carlos Enrique Toro-Gutiérrez, Francisco Juan Vargas Grajales, Susan Martínez, Linda Ibatá
Article information
These are the options to access the full texts of the publication Revista Colombiana de Reumatología (English Edition)
Subscriber
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail